Approval · Notice of Compliance 4686 · 1996
URSOFALK: Notice of Compliance 4686
Issued March 11, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4686
- Date
- March 11, 1996
- Company
- Jouveinal Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for the management of cholestatic liver diseases such as primary biliary cirrhosis
- Therapeutic class
- Litholytic agent & cholestatic liver diseases
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| URSOFALK | Not yet assigned | — |
Medicinal ingredients
- URSODIOL 250 MG per CAP